Description
A specific antagonist of the type 4 PGE2 receptor EP4; possesses significant anti-tumor growth activity in multiple preclinical tumor models through modulating myeloid cells
Formal name: 4-[(1S)-1-[[[3-(difluoromethyl)-1-methyl-5-[3-(trifluoromethyl)phenoxy]-1H-pyrazol-4-yl]carbonyl]amino]ethyl]-benzoic acid
Synonyms:
Molecular weight: 483.4
CAS: 1369489-71-3
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Antagonists||Research Area|Cancer||Research Area|Immunology & Inflammation|Immunotherapeutics||Research Area|Immunology & Inflammation|Innate Immunity||Research Area|Lipid Biochemistry|Cyclooxygenase Pathway